Moderna filing for emergency use of coronavirus vaccine in U.S.

U.S. biotechnology firm Moderna Inc. said it is filing on Monday for emergency use authorization for its experimental coronavirus vaccine from U.S. and European regulators, after finding the vaccine more than 94 percent effective against the COVID-19 disease.The announcement came after pharmaceutical giant Pfizer Inc., along with its German partner BioNTech SE, became the first to apply for such authorization of a coronavirus vaccine from the U.S. Food and Drug Administration earlier in November.Moderna said in a press release that its latest analysis of its final-stage clinical trial showed t…

Read More

HEDGE accordingly